Developments BrainsWay Deep TMS study shows 70% reduction in suicidal ideation in MDD BrainsWay (NASDAQ: BWAY; TASE: BWAY) has announced the publication of new peer-reviewed data in the Journal of Affective Disorders demonstrating significant reductions in suicidal ideation among patients with major... August 27, 2026